AU2013221420B2 - Methods of producing sulfilimine compounds - Google Patents

Methods of producing sulfilimine compounds Download PDF

Info

Publication number
AU2013221420B2
AU2013221420B2 AU2013221420A AU2013221420A AU2013221420B2 AU 2013221420 B2 AU2013221420 B2 AU 2013221420B2 AU 2013221420 A AU2013221420 A AU 2013221420A AU 2013221420 A AU2013221420 A AU 2013221420A AU 2013221420 B2 AU2013221420 B2 AU 2013221420B2
Authority
AU
Australia
Prior art keywords
compound
alkyl
hypochlorite
cyanamide
sulfilimine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2013221420A
Other versions
AU2013221420A1 (en
Inventor
Timothy J. Adaway
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Corteva Agriscience LLC
Original Assignee
Corteva Agriscience LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Corteva Agriscience LLC filed Critical Corteva Agriscience LLC
Publication of AU2013221420A1 publication Critical patent/AU2013221420A1/en
Application granted granted Critical
Publication of AU2013221420B2 publication Critical patent/AU2013221420B2/en
Assigned to CORTEVA AGRISCIENCE LLC reassignment CORTEVA AGRISCIENCE LLC Request to Amend Deed and Register Assignors: DOW AGROSCIENCES, LLC
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/32—Sulfur atoms
    • C07D213/34—Sulfur atoms to which a second hetero atom is attached
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/57—Nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/16—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/08—1,2,4-Thiadiazoles; Hydrogenated 1,2,4-thiadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyridine Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Abstract

Methods of producing a sulfilimine compound, such as

Description

METHODS OF PRODUCING SULFILIMINE COMPOUNDS
PRIORITY CLAIM
This application claims the benefit of U.S. Provisional Patent Application Serial No. 61/599,489, filed February 16, 2012.
TECHNICAL FIELD
Embodiments of the present disclosure relate to methods of producing sulfilimine compounds, such as methods of producing sulfilimine compounds from sulfide compounds.
BACKGROUND
Substituted sulfilimine compounds are useful intermediates in the preparation of sulfoximine compounds, which have insecticidal activity. Cyano-substituted sulfilimine compounds have been prepared by reaction of a corresponding sulfide compound with cyanamide in the presence of iodobenzene diacetate. However, iodobenzene diacetate is expensive and causes waste disposal problems.
Substituted sulfilimine compounds have also been prepared by replacing the iodobenzene diacetate with hypochlorite. A corresponding sulfide compound is reacted with cyanamide in the presence of the hypochlorite. However, a corresponding sulfoxide compound is also produced as one of the reaction by-products. The yield of the substituted sulfilimine compound is affected by the amount of reaction by-products produced. For instance, 5-[l-(methylthio)ethyl]-2-trifluoromethylpyridine (the sulfide compound) is oxidized to A-cyano-S-methyl-.S-f 1 -(6-trifluoromethyl-3-pyridinyl)ethyl]sulfilimine (the sulfilimine compound) in the presence of sodium hypochlorite and cyanamide. A by-product of the oxidation reaction is 5-[l-(methylsulfinyl)ethyl]-2-trifluoromethylpyridine (the sulfoxide compound), which may be produced at 10% or greater. It would be desirable to have a process for producing the sulfilimine compound at higher yields, such as by decreasing the amount of sulfoxide compound produced.
BRIEF SUMMARY
In one aspect of the invention there is provided a method of producing a sulfilimine compound, comprising: combining a sulfide compound, cyanamide, a hypochlorite compound, and a base; and oxidizing the sulfide compound to form a sulfilimine compound,wherein the sulfide compound having the chemical structure:
where Het is a moiety selected from the group consisting of
X is a moiety selected from the group consisting of a halogen, a C1-C4 alkyl, a C1-C4 haloalkyl, a C2-C4 alkenyl, a C2-C4 alkynyl, a C2-C4 haloalkenyl, a C1-C4 alkoxy, a C1-C4 haloalkoxy, CN, NO2, SOmR6 where m is an integer from 02, COOR4, and CONR4R5; Y is a moiety selected from the group consisting of hydrogen, a halogen, a C1-C4 alkyl, a C1-C4 haloalkyl, a C2-C4 alkenyl, a C2-C4 alkynyl, a C2-C4 haloalkenyl, a C1-C4 alkoxy, a C1-C4 haloalkoxv. CN, NO2, SOmR| where m is an integer from 0-2, COOR4, CONR4R5, aryl, and heteroaryl; n is an integer from 0-3; L is either a single bond, -CH(CH2)P- where Ri, S, and L taken together are a 4-, 5-, or 6-membered ring and p is an integer from 1-3, -CH(CH->OOi:)- where Ri, S, and L taken together are a 6-membered ring, or -Cl I- where L, R2, and the common carbon to which they connect taken together are a 4-, 5-, or 6-membered ring with up to, but no more than, 1 heteroatom;
Ri is a moiety selected from the group consisting of a C1-C4 alkyl, a C1-C4 haloalkyl, a C3-C6 alkenyl, a C3-C6 alkynyl, a C3-C6 haloalkenyl, an arylalkyl, a heteroarylalkyl, or -CH2- in eases where R|, S, and L taken together are a 4-, 5-, or 6-membered ring; each of R2 and R3 is independently selected from the group consisting of hydrogen, halogen, C1-C4 alkyl, a C1-C4 haloalkyl, a C2-C4 alkenyl, a C2-C4 alkynyl, a C2-C4 haloalkenyl, a C1-C4 alkoxy, a C1-C4 haloalkoxy, CN, SOmR6 where m is an integer from 0-2, COOR4, CONR4R5. an arylalkyl, a heteroarylalkyl, or R2 and R3 and the common carbon to which they attach form a 3-6 membered ring; each of R4 and R5 is independently selected from the group consisting of hydrogen, a C1-C4 alkyl, a C1-C4 haloalkyl, a Cs-Ce alkenyl, a C3-C6 alkynyl, a C3-C6 haloalkenyl, an aryl, a heteroaryl, an arylalkyl, or a heteroarylalkyl; and R6 is a moiety selected from the group consisting of a C1-C4 alkyl, a C1-C4 haloalkyl, a C3-C6 alkenyl, a C3-C6 alkynyl, a C3-C6 haloalkenyl, an arylalkyl, and a heteroarylalkyl.
In another aspect of the invention there is provided a method of producing a sulfilimine compound, comprising: combining a 5-[l-(alkylthio)alkyl]-2-trifluoromethyipyridine compound, cyanamide, a hypochlorite compound, and a base to form a sulfilimine compound.
In yet another aspect of the invention there is provided a method of producing A-cyano-S'-methyl-S- [ 1 -(6-trifluoromethyl-3 -pyridinyl)ethyl] sulfilimine that comprises providing a feed stream comprising 5-[l-(methylthio)ethyl]-2-trifluoromethylpyridine and acidic impurities. An aqueous cyanamide solution, an aqueous sodium hypochlorite solution, an aqueous sodium hydroxide solution, and acetonitrile are combined with the feed stream. An organic phase comprising N-cyano-S-methy l-S-11 -(6-trifluoromethyl-3-pyridinyl)ethyl]sulfilimine is separated from an aqueous phase.
DETAILED DESCRIPTION A method of producing a sulfilimine compound from a sulfide compound is described. The method provides an increased yield of the sulfilimine compound and a decreased yield of reaction by-products. The sulfilimine compound is synthesized by combining a sulfide compound, cyanamide, a hypochlorite compound, a base, and, optionally, a buffer. The sulfide compound may be provided in a sulfide feed stream, which is produced by a previous reaction in the overall process of producing the sulfilimine compound. By way of example, the sulfide feed stream may be a feed stream from a reaction to produce the sulfide compound from a substituted enamine compound. However, the sulfide feed stream may be produced from other types of reactions. The sulfide feed stream may be used directly from the previous reaction, or may be subjected to conventional solvent exchange process, conventional solvent concentration process, or conventional purification techniques before use in the reaction to produce the sulfilimine compound. The sulfide compound in the sulfide feed stream may be at least 90% pure. The sulfide feed stream may also include acidic impurities, such as by-products from the previous reaction. Acidic impurities may also be present in the cyanamide.
The cyanamide solution and sulfide compound may be combined in the organic solvent, the base and buffer, if present, added thereto, followed by addition of the hypochlorite compound. A small amount of aqueous sodium bisulfite solution may be added to the mixture to react with any excess hypochlorite compound. The presence of excess hypochlorite compound may be determined by testing with starch-iodide paper. After a sufficient amount of time has passed for the reagents to react, an aqueous phase may be separated from an organic phase, which contains the sulfilimine compound.
The organic phase including the sulfilimine compound may be used directly in a subsequent oxidation to produce an insecticidal sulfoximine compound by conventional techniques or the sulfilimine compound may be isolated and purified by conventional techniques, which are not described in detail herein.
As used herein, the terms “alkyl,” “alkenyl,” and “alkynyl,” as well as derivative terms such as “alkoxy,” “acyl,” “alkylthio,” “arylalkyl,” “heteroarylalkyl,” and “alkylsulfonyl,” include within their scope straight chain, branched chain, or cyclic moieties. Thus, the term “alkyl” may include, but is not limited to, methyl, ethyl, 1-methylethyl, propyl, 1,1-dimethylethyl, or cyclopropyl. Unless specifically stated otherwise, each may be unsubstituted or substituted with one or more substituents including, but not limited to, a halogen, hydroxy, an alkoxy, an alkylthio, a Ci-Ce acyl, a formyl, cyano, an aryloxy, or an aryl group, provided that the substituents are sterically compatible and the rules of chemical bonding and strain energy are satisfied. The terms “haloalkyl” and “haloalkenyl” include alkyl and alkenyl groups substituted with from one to the maximum possible number of halogen atoms, all combinations of halogens included. The terms “halogen” or “halo” includes fluorine, chlorine, bromine, iodine, or combinations thereof. In one embodiment, the halogen is fluorine. The terms “alkenyl” and “alkynyl” are intended to include one or more unsaturated bonds.
The term “aryl” refers to a phenyl, indanyl, or naphthyl group. The term “heteroaryl” refers to a 5- or 6-membered aromatic ring containing one or more heteroatoms, such as nitrogen, oxygen, or sulfur. These heteroaromatic rings may be fused to other aromatic systems. The aryl or heteroaryl groups may be unsubstituted, or substituted with one or more substituents selected from a halogen, hydroxy, nitro, cyano, an aryloxy, formyl, a CrC6 alkyl, a C2-C6 alkenyl, a C2-C6 alkynyl, a Cj-C6 alkoxy, a halogenated C\-C(, alkyl, a halogenated C1-C6 alkoxy, a C1-C6 acyl, a C1-C6 alkylthio, a C1-C6 alkylsulfinyl, a C1-C6 alkylsulfonyl, an aryl, a C1-C6 0C(0)alkyl, a Cj-C6 NHC(0)alkyl, C(0)0H, a C,-C6C(0)Oalkyl, C(0)NH2, a CrC6C(0)NHalkyl, or a C1-C6 C(0)N(alkyl)2, provided that the substituents are sterically compatible and the rules of chemical bonding and strain energy are satisfied.
The sulfilimine compound produced by the oxidation reaction may be a substituted sulfilimine compound, such as one of the compounds described in United States Patent No. 7,868,027, the disclosure of which is incorporated by reference herein in its entirety. By way of example, the sulfilimine compound may have the following chemical structure:
where “Het” is a heteroaryl group and is selected from one of the following chemical structures: 5
X is a halogen, a C1-C4 alkyl, a C1-C4 haloalkyl, a C2-C4 alkenyl, a C2-C4 alkynyl, a C2-C4 haloalkenyl, a C1-C4 alkoxy, a C1-C4 haloalkoxy, CN, NO2, SOmR6 where m is an integer from 0-2, COOR4, or CONR4R5; Y is hydrogen, a halogen, a C1-C4 alkyl, a C1-C4 haloalkyl, a C2-C4 alkenyl, a C2-C4 alkynyl, a C2-C4 haloalkenyl, a C1-C4 alkoxy, a C1-C4 haloalkoxy, CN, NO2, SOmRi where m is an integer from 0-2, COOR4, CONR4R5, aryl, or heteroaryl; n is an integer from 0-3; L is either a single bond, -CH(CH2)P- where Rj, S, and L taken together are a 4-, 5-, or 6-membered ring, and p is an integer from 1-3, -CH(CH20CH2)- where Rj, S, and L taken together are a 6-membered ring, or -CH- where L, R2, and the common carbon to which they connect taken together are a 4-, 5-, or 6-membered ring with up to, but no more than, 1 heteroatom;
Ri is a C1-C4 alkyl, a C1-C4 haloalkyl, a C3-C6 alkenyl, a C3-C6 alkynyl, a C3-C6 haloalkenyl, an arylalkyl, a heteroarylalkyl, or -CH2- in cases where R]; S, and L taken together are a 4-, 5-, or 6-membered ring; R2 and R3 independently are hydrogen, halogen, C1-C4 alkyl, a C1-C4 haloalkyl, a C2-C4 alkenyl, a C2-C4 alkynyl, a C2-C4 haloalkenyl, a C1-C4 alkoxy, a C1-C4 haloalkoxy, CN, SOmR6 where m is an integer from 0-2, COOR4, CONR4R5, an arylalkyl, a heteroarylalkyl, or R2 and R3 and the common carbon to which they attach form a 3-6 membered ring; R4 and R5 independently are hydrogen, a C1-C4 alkyl, a C1-C4 haloalkyl, a C3-C(, alkenyl, a C3-C6 alkynyl, a C3-C6 haloalkenyl, an aryl, a heteroaryl, an arylalkyl, or a heteroarylalkyl; and R6 represents a C1-C4 alkyl, a C1-C4 haloalkyl, a C3-C6 alkenyl, a C3-C6 alkynyl, a C3-C6 haloalkenyl, an arylalkyl, or a heteroarylalkyl.
In one embodiment, the sulfilimine compound is A-cyano-i'-methyl-S-f 1 -(6-trifluoromethyl-3 -pyridinyl)ethyl] sulfilimine.
The sulfilimine compound may be produced by reacting a corresponding sulfide compound with the hypochlorite compound, cyanamide, base, and buffer, if present. The sulfide compound may have the following chemical structure:
where Het, R|, R2, R3, and L are defined as previously discussed, and n is an integer from 0-3. In one embodiment, the sulfide compound is a 2-trifluoromethyl-5-(l-substituted)alkylthiopyridine compound having the following chemical structure:
where R7 and Rg are independently H, C1-C4 alkyl, or either of R7 or Rg taken together with R9 is a 4- to 6-membered saturated ring or R7 taken together with Rs is a 3- to 6-membered saturated ring optionally substituted with an O or a N atom, and R9 is a C1-C4 alkyl or R9 taken together with either of R7 or R8 is a 4- to 6-membered saturated ring. In one embodiment, the 2-trifluoromethyl-5-(l-substituted)alkylpyridine compound is 5-[l-(methylthio)ethyl]-2-trifluoromethylpyridine.
In one embodiment, the 2-trifluoromethyl-5-( 1 -substituted)alkylthiopyridine compound is 5-[l-(methylthio)ethyl]-2-trifluoromethylpyridine and the sulfilimine compound produced therefrom is /V-cyano-.S'-methyl-.S'-f 1 -(6-trifluoromethyl-3-pyridinyl)ethyl]sulfilimine with 5-[l -(methylsulfinyl)-ethyl]-2-trifluoromethylpyridine potentially produced as a sulfoxide by-product of the oxidation reaction. However, the addition of the base and buffer, if present, may reduce the amount of sulfoxide byproduct produced by the reaction.
The 2-trifluoromethyl-5-(l-substituted)alkylpyridine compound may be oxidized to the corresponding sulfilimine compound, which may subsequently be oxidized to produce a sulfoximine compound having insecticidal activity. While the examples herein describe the production of /V-cyano-.S-methyl-5-[ 1 -(6-trifluoromethyl- 3-pyridinyl)ethyl]sulfilimine from 5-[l-(methylthio)ethyl]-2-trifhioromethylpyridine, a similar method may be used to form other sulfilimine compounds from their corresponding sulfide compounds.
The 2-trifluoromethyl-5-(l-substituted)alkylthiopyridine compound may be oxidized to the corresponding sulfilimine compound by reacting the 2-trifluoromethyl- 5-(l-substituted)-alkylthiopyridine compound, cyanamide, hypochlorite compound, base, and buffer, if present. The oxidation reaction may be conducted in a suitable organic solvent that is substantially inert to the strong oxidizing conditions of the reaction and that facilitates partitioning of the resulting sulfilimine compound. By way of example, the organic solvent may be an aliphatic hydrocarbon, such as petroleum ether; a halogenated aliphatic or halogenated aromatic hydrocarbon, such as dichloromethane, chloroform, 1,2-dichloroethane, or dichlorobenzene; or an aliphatic or aromatic nitrile, such as acetonitrile (ACN) or benzonitrile. In one embodiment, the organic solvent is acetonitrile. The oxidation reaction may also be conducted in a biphasic solvent system that includes a mixture of the organic solvent, such as a halogenated hydrocarbon, and water. The oxidation reaction may be conducted at a temperature within a range of from about -40°C to about 3 CPC, such as from about - 10°C to about 10°C, or from about -5°C to about 0°C. The preferred method is to slowly add the hypochlorite compound to a mixture of the 2-trifluoromethyl-5-(l-substituted)alkylthiopyridine compound, solvent, cyanamide, base, and buffer, if present. The reagents, once completely mixed, may be stirred for from approximately 15 minutes to approximately 2 hours, such as for approximately 30 minutes, to provide sufficient time for the oxidation reaction to occur.
The 2-trifhioromethyl-5-(l-substituted)alkylthiopyridine compound, cyanamide, base, and buffer (if present) may be combined in any order, with the hypochlorite solution being slowly added last to help control the heat of reaction. By way of example, the base may be added to the sulfide feed stream containing the 2-trifluoromethyl-5-(l-substituted)alkylthiopyridine compound, followed by addition of the remaining reagents, with the hypochlorite compound added last. Other addition orders are possible but precautions need to be taken to deal with unstable intermediates. The base may neutralize the acidic impurities in the sulfide feed stream or in the cyanamide, enabling production of a higher yield of the sulfilimine compound.
The sulfide feed stream including the 2-trifluoromethyl-5-(l-substituted)alkyl-thiopyridine compound may be contacted with a solution of the base, followed by addition of the cyanamide, hypochlorite compound, and buffer (if present). The sulfide feed stream may include the 2-trifluoromethyl-5-(l-substituted)alkylthiopyridine compound and acidic impurities, which may include, but are not limited to, acetic acid, hydrochloric acid, or other acidic by-products from a previous reaction. The sulfide feed stream may include the 2-trifluoromethyl-5-(l-substituted)alkylthiopyridine compound and from about 1 x 10'5 moles of acidic impurities to about 1 x 10-4 moles of acidic impurities per gram. The cyanamide is buffered to a pH of 4 to 5 to improve its storage stability, thus the cyanamide will add acidity to the system.
The base may be a suitable base of sufficient strength to neutralize the acidic impurities in the sulfide feed stream or the cyanamide. The base may be added to the sulfide feed stream. The base may be an alkali metal hydroxide, an alkali metal carbonate, or combinations thereof. By way of example, the base may be lithium hydroxide, sodium hydroxide (NaOH), potassium hydroxide, lithium carbonate, sodium carbonate, potassium carbonate, trisodium and tripotassium phosphates, or combinations thereof. In one embodiment, the base is sodium hydroxide. In another embodiment, the base is sodium carbonate. The base used in the oxidation reaction may be a solid or an aqueous solution. The base may be combined with the additional reagents to neutralize the acidic impurities in the sulfide feed stream or the cyanamide. The moles of base should meet or exceed the moles of acid.
The cyanamide used in the oxidation reaction may be a solid or an aqueous solution that includes from approximately 40% by weight to approximately 60% by weight of cyanamide. In one embodiment, the cyanamide is a solution including 50% by weight of cyanamide in water. In a particular embodiment, the oxidation reaction may utilize a stoichiometric amount of cyanamide relative to the 2-trifluoromethyl-5-(l-substituted)alkylthiopyridine compound, or from about 1.0 molar equivalents to about up to 1.6 molar equivalents of the cyanamide relative to the 2-trifluoromethyl-5-(l-substituted)alkylthiopyridine compound. To ensure complete conversion of the 2-trifluoromethyl-5-(l-substituted)alkylthiopyridine compound, an excess of the cyanamide (relative to the 2-trifluoromethyl-5-(l-substituted)alkylthiopyridine compound) may be used.
The hypochlorite compound used in the oxidation reaction may be a hypochlorite solution. The hypochlorite compound may be a metallic salt of hypochlorous acid. The metallic salt may be a Group I alkali metal salt or a Group II alkaline earth metal salt of hypochlorous acid, such as sodium hypochlorite or calcium hypochlorite. The hypochlorite solution may include the metallic salt of hypochlorous acid and water. The hypochlorite solution may include from about 2% by weight to about 20% by weight of the metallic salt of hypochlorous acid, such as from about 12.5% by weight to about 17% by weight. The hypochlorite solution may be commercially available, such as from Sigma-Aldrich Co. or other chemical supply company. Higher concentrations of chlorine in the hypochlorite solution may be achieved by adding chlorine to the hypochlorite solution to provide a solution containing up to approximately 20% of the hypochlorite compound. In particular embodiments, a stoichiometric amount of the hypochlorite compound may be utilized relative to the 2-trifluoromethyl-5-(l-substituted)alkylthiopyridine compound or from about 1.0 to about 1.2 molar equivalents of the hypochlorite compound may be used relative to the 2-trifluoromethyl-5-(l-substituted)alkylthiopyridine compound. To ensure complete conversion of the 2-trifluoromethyl-5-(l-substituted)alkylthiopyridine compound, an excess of the hypochlorite (relative to the 2-trifluoromethyl-5-(l-substituted)alkylthiopyridine compound) may be used. In one embodiment, the hypochlorite solution includes 13% by weight of sodium hypochlorite. In another embodiment, the hypochlorite solution includes 15% by weight of sodium hypochlorite. In yet another embodiment, the hypochlorite solution includes 17% by weight of sodium hypochlorite.
The buffer may be a phosphate buffer, such as sodium dihydrogen phosphate. The buffer may be added to the sulfide feed stream or the cyanamide. The buffer may be present at from about 1 mole % to about 5 mole % relative to the 2-trifluoromethyl- 5-(l-substituted)alkylthiopyridine compound. After addition of the buffer, a known amount of the base may be added such that all of the phosphate buffer is in the form of disodium hydrogen phosphate or tri-sodium phosphate.
After a sufficient amount of time has passed for the reagents to react, an aqueous phase may be separated from an organic phase, which contains the corresponding sulfilimine compound (A-cyano-5-methyl-5-[l-(6-trifluoromethyl-3-pyridinyl)ethyl]sulfilimine). The organic phase including the corresponding sulfilimine compound may be used directly in a subsequent reaction to produce an insecticidal sulfoximine compound by conventional techniques, or the sulfilimine compound may be isolated and purified by conventional techniques, which are not described in detail herein. The use of the base and buffer, if present, in the oxidation reaction may reduce the formation of 5-[l-(methylsulfinyl)-ethyl]-2-trifluoromethylpyridine as a by-product of the oxidation reaction, resulting in an increased yield of the A'-cyano-.S'-methyl-5-[ 1 -(6-trifluoromethyl-3-pyridinyl)ethyl]sulfilimine.
In an additional embodiment, the pH of a mixture including the 2-trifhioromethyl-5-(l-substituted)alkylthiopyridine compound, cyanamide, and hypochlorite compound may be determined, and then a desired amount of the base added to neutralize the mixture. By way of example, a sufficient amount of the base may be added to the mixture to neutralize the acidic impurities therein. The mixture may be titrated with the solution of base to neutralize the acidic impurities. By first quantitating the acidity of the mixture, the mixture may be neutralized without adding excess base, which can result in incomplete conversion of the 2-trifluoromethyl-5-(l-substituted)alkylthiopyridine compound.
In another embodiment, an excess of the buffer may be added to the mixture including the 2-trifhioromethyl-5-(l-substituted)alkylthiopyridine compound and cyanamide followed by addition of the base. By adding an excess amount of the base, neutralization of the acidic impurities may be ensured without having to first measure the acidity of the mixture.
The following examples serve to explain embodiments of the present disclosure in more detail. These examples are not to be construed as being exhaustive or exclusive as to the scope of this invention.
Examples Example 1
Preparation of yV-cyano-tS-methyl-.S,-[ 1 -(6-trifluoromcthyl-3-pyridinyl)ethyl]sulfilimine: 5-[ 1 -(methylthio)ethyl]-2-trifluoromethylpyridine pre-treatment The starting sulfide compound was pre-treated with base to remove acidic compounds. 5-[ 1 -methylthio)ethyl]-2-trifluoromethylpyridine was dissolved in hexane and washed with an equal volume of 1% aqueous sodium hydroxide (NaOH). The resulting organic phase was evaporated and the remaining oil used as feed for the sulfilimine reaction. The above treated 5-[l-methylthio)ethyl]-2-trifluoromethylpyridine, 10.6g (about 0.045 moles) was mixed with 39.2g of acetonitrile and 5.06g (0.059 moles) of 50% aqueous cyanamide in a 250 ml flask equipped with electric stirrer (half moon agitator), thermowell, nitrogen pad, and addition funnel. Using a bath the flask was cooled to -7°C. A 6.14% solution of sodium hypochlorite (68. lg, 0.056 moles) was slowly added over 88 minutes, keeping the temperature at -7°C. After a 35 minute post reaction period the excess oxidizing agents were quenched with sodium bisulfite to give a negative test to starch-iodide paper. The mixture was wanned to room temperature and phase separated. The total accountability as the sulfilimine in the two phases was 90.1% and the total accountability as the sulfoxide was 10.1%. Without first treating the 5-[l-methylthio)ethyl]-2-trifluoromethylpyridine with the hexane and base, the accountibilities of the sulfilimine and sulfoxide respectively were 85.6% and 13.7%.
Example 2
Preparation of jV-cyano-5'-methyl-5'-[l -(6-trifluoromethyl-3-pyridinyl)ethyl]sulfilimine: sodium dihydrogen phosphate and base addition
An acid (sodium dihydrogen phosphate) was added to the mixture to simulate the effects of low levels of acid in the sulfide feed stream. Cyanamide (1.4 molar equivalents relative to the 5-[l-(methylthio)ethyl]-2-trifhioromethylpyridine), water, and 2 mole% of the sodium dihydrogen phosphate were mixed until homogeneous. ACN and the sulfide feed stream (5 - [ 1 -(methylthio)ethyl] -2-trifluoromethylpyridine (94% purity)) were then added. The mixture turned cloudy, indicating precipitation of some of the sodium dihydrogen phosphate. The mixture was cooled to the desired reaction temperature and 1.25 molar equivalents of 13% sodium hypochlorite was slowly added. Additional oxidation reactions were conducted, adding sodium carbonate CN^CO;)) or NaOH along with the sodium dihydrogen phosphate. All oxidation reactions used 1.4 molar equivalents of cyanamide and 1.25 molar equivalents of 13% sodium hypochlorite relative to the 5-[l-(methylthio)ethyl]-2-trifluoromethylpyridine. All runs resulted in 99+% conversion of the 5-[l-(methylthio)ethyl]-2-trifluoromethylpyridine to reaction products. The results are summarized in Table 1.
Table 1
The addition of the sodium dihydrogen phosphate to the mixture almost doubled the amount of sulfoxide compound (5-[l-(methylsulfinyl)ethyl]-2-trifluoromethylpyridine) produced, thus reducing the yield of sulfilimine compound (A/-cyano-.S,-methykS,-[l-(6-trifluoromethyl-3-pyridinyl)ethyl]sulfiliminc) by around 5%. The addition of the sodium carbonate had minimal effect. The addition of the sodium hydroxide increased the yield of sulfilimine compound to approximately the same as the baseline or even slightly better. The results in Table 1 indicate that the addition of NaOH to the sulfide feed stream contaminated with acids increased the yield of sulfilimine compound.
Example 3
Preparation of Ai-cyano-5-methyl-5'-[l-(6-trifluoromethyl-3-pyridinyl)ethyl]sulfilimine: base addition A sulfide feed stream known to include acidic impurities was titrated with dilute NaOH and found to contain about 3.2 x 10'5 moles of acid/gram. The cyanamide was titrated with dilute NaOH and found to contain about 2.01 x 10'5 moles of acid/ gram. Thus, for the oxidation reaction of 5-[l-(methylthio)ethyl]-2-trifluoromethylpyridine with cyanamide and sodium hypochlorite (13%) conducted on a 0.047 mole scale, the total moles of acid in the mixture was 0.00041 moles. The effect of adding NaOH to the mixture to neutralize the acidity in the sulfide feed stream and the cyanamide was determined. The NaOH was added as a 25% aqueous solution and stirred for about 5 minutes before adding the sodium hypochlorite. The results are summarized in Table 2.
Table 2
Table 2 indicates that adding the NaOH to the mixture increased the yield of the sulfilimine compound and decreased the yield of the sulfoxide compound.
Example 4
Preparation of Ar-cyano-5'-methyl-1S,-[l-(6-triiluoromethyl-3-pyridinyl)ethyl] sulfilimine: buffer addition
The effect of adding a phosphate buffer to the sulfide feed stream on the yields of sulfilimine compound and sulfoxide compound was investigated in accordance with the procedures disclosed in Example 1 using 12% aqueous sodium hypochlorite. The phosphate buffer was trisodium phosphate or sodium dihydrogen phosphate, with sufficient sodium hydroxide used to generate the trisodium salt. The results are summarized in Table 3.
Table 3
The addition of the phosphate buffer to the sulfide feed stream resulted in an increased yield of sulfilimine compound, as evidenced in Table 3 by the difference in average sulfimine compound yield between the runs including the phosphate buffer compared to those lacking the phosphate buffer.
The effect on yields of the sulfilimine compound and sulfoxide compound by varying the amount of phosphate buffer used was also investigated. The phosphate buffer was added in such a way as to produce trisodium phosphate. The results are summarized in Table 4.
Table 4
A positive effect of adding the phosphate buffer to the sulfide feed stream was seen in the range of evaluated 1-5 mole% of phosphate buffer relative to the sulfide compound.
While the invention may be susceptible to various modifications and alternative forms, specific embodiments have been described by way of example in detail herein. However, it should be understood that the invention is not intended to be limited to the particular forms disclosed. Rather, the invention is to cover all modifications, equivalents, and alternatives falling within the scope of the invention as defined by the following appended claims and their legal equivalents.

Claims (18)

  1. CLAIMS What is claimed is:
    1. A method of producing a sulfilimine compound, comprising: combining a sulfide compound, cyanamide, a hypochlorite compound, and a base; and oxidizing the sulfide compound to form a sulfilimine compound, wherein the sulfide compound having the chemical structure:
    wherein Het is a moiety selected from the group consisting of
    X is a moiety selected from the group consisting of a halogen, a C1-C4 alkyl, a C3-C4 haloalkyl, a C2-C4 alkenyl, a C2-C4 alkynyl, a C2-C4 haloalkenyl, a C1-C4 alkoxy, a C1-C4 haloalkoxy, CN, NO2, SOmR6 where m is an integer from ΟΙ, COOR4, and CONR4R5; Y is a moiety selected from the group consisting of hydrogen, a halogen, a C1-C4 alkyl, a C1-C4 haloalkyl, a C2-C4 alkenyl, a C2-C4 alkynyl, a C2-C4 haloalkenyl, a C1-C4 alkoxy, a C1-C4 haloalkoxy, CN, NO2, SOmR] where m is an integer from 0-2, COOR4, CONR4R5, aryl, and heteroaryl; n is an integer from 0-3; L is either a single bond, -CH(CH2)P- where Ri, S, and L taken together are a 4-, 5-, or 6-membered ring and p is an integer from 1-3, -CIRCINOChb)- where Ri, S, and L taken together are a 6-membered ring, or -CH- where L, R2, and the common carbon to which they connect taken together are a 4-, 5-, or 6-membered ring with up to, but no more than, 1 heteroatom; Ri is a moiety selected from the group consisting of a C1-C4 alkyl, a C1-C4 haloalkyl, a C3-C6 alkenyl, a C3-C6 alkynyl, a C3-C6 haloalkenyl, an aryl alkyl, a heteroarylalkyl, or -CH2- in cases where Ri, S, and L taken together are a 4-, 5-, or 6-membered ring; each of R2 and R3 is independently selected from the group consisting of hydrogen, halogen, C1-C4 alkyl, a C1-C4 haloalkyl, a C2-C4 alkenyl, a C2-C4 alkynyl, a C2-C4 haloalkenyl, a C1-C4 alkoxy, a C1-C4 haloalkoxy, CN, S()mR6 where m is an integer from 0-2, COOR4, CONR4R5, an arylalkyl, a heteroarylalkyl, or R2 and R3 and the common carbon to which they attach form a 3-6 membered ring; each of R4 and R5 is independently selected from the group consisting of hydrogen, a C1-C4 alkyl, a C1-C4 haloalkyl, a C3-C6 alkenyl, a C3-C6 alkynyl, a C3-C6 haloalkenyl, an aryl, a heteroaryl, an arylalkyl, or a heteroarylalkyl; and R6 is a moiety selected from the group consisting of a C1-C4 alkyl, a C1-C4 haloalkyl, a C3-Ce alkenyl, a C3-C6 alkynyl, a C3-C6 haloalkenyl, an arylalkyl, and a heteroarylalkyl.
  2. 2. The method of claim 1, further comprising adding a buffer to the sulfide compound, cyanamide, hypochlorite compound, and base.
  3. 3. The method of claim 1, wherein the sulfide compound has the chemical structure:
  4. 4. The method of claim 1, wherein the base is selected from the group consisting of an alkali metal hydroxide, an alkali phosphate, an alkali metal carbonate, and combinations thereof.
  5. 5. A method of producing a sulfilimine compound, comprising: combining a 5-[l-(alkylthio)alkyl]-2-trifluoromethylpyridine compound, cyanamide, a hypochlorite compound, and a base to form a sulfilimine compound.
  6. 6. The method of claim 5, wherein the 5-[l-(alkythio)alkyl]-2-tri lluromethylpyridine compound has the following formula:
    wherein each of R7 and Rg is independently selected from the group consisting of hydrogen, C1-C4 alkyl, either of R7 or Rg taken together with R9 is a 4- to 6-membered saturated ring or R7 taken together with Rg is a 3- to 6-membered saturated ring optionally substituted with an O or a N atom, and R<> is a C1-C4 alkyl or R<> taken together with either of R7 or Rg is a 4- to 6-membered saturated ring.
  7. 7. The method of claim 5, wherein the hypochlorite compound is a hypochlorite compound solution comprising from about 2% by weight to about 20% by weight of a metallic salt of hypochlorous acid.
  8. 8. The method of claim 5., wherein combining a 5 - [ 1 -(alkylthio)alkyl] -2-trifluromethylpyridine compound, cyanamide, a hypochlorite compound, and a base comprises combining the 5-[l-(alkylthio)alkyl]-2-trifluromethylpyridme compound, an aqueous cyanamide solution, an aqueous solution of the hypochlorite compound, and the base.
  9. 9. The method of claim 5, wherein the base is chosen from an alkali metal hydroxide, an alkali metal carbonate, Or combinations thereof.
  10. 10. The method of claim 9, wherein the base is sodium hydroxide or sodium carbonate.
  11. 11. The method of claim 5, further comprising adding a phosphate buffer to the feed stream.
  12. 12. The method of claim 1 or 7, wherein combining a sulfide compound, cyanamide, a hypochlorite compound, and a base to form a sulfilimine compound comprises reacting the sulfide compound, cyanamide, hypochlorite compound, and base at a temperature from about -40°C to about 30°C.
  13. 13. A method of producing Adcyano-S-methykS'- [ 1 -(6-trifluoromethyl-3 -pyridinyl)ethyl] sulfilimine, comprising: providing a feed stream comprising 5-[l-(methylthio)ethyl]-2-trifluoromethylpyridine and acidic impurities; combining an aqueous cyanamide solution, an aqueous sodium hypochlorite solution, an aqueous sodium hydroxide solution, and acetonitrile with the feed stream; and separating an organic phase comprising A^oyano-S'-methyl-S-[1-(6-trifluoromethyl-3-pyridinyl)ethyl] sulfilimine from an aqueous phase.
  14. 14. The method of claim 13 , wherein the feed stream comprises from about 1 x I D'5 moles of acidic impurities to about 1 x 104 moles of acidic impurities per gram of feed.
  15. 15. The method of claim 13, wherein the aqueous sodium hypochlorite solution comprises from about 12.5% by weight to about 20% by weight.
  16. 16. The method of claim 15, wherein the aqueous sodium hypochlorite solution comprises from about 12.5% by weight to 17% by weight of sodium hypochlorite.
  17. 17. The method of claim 13, comprising combining from about 1.0 molar equivalents to about 1.6 molar equivalents of cyanamide relative to the 5-[l-(methyhhio)ethyl]-2-trifhioromethylpyridine, from about 1.0 to about 1.2 molar equivalents of sodium hypochlorite relative to the 5-[l-(methylthio)ethyl]-2-trifluoromethylpyridine, the aqueous sodium hydroxide solution, and acetonitrile with the feed stream.
  18. 18. The method of claim 17, wherein molar ratio of cyanamide to sodium hypochlorite is about 1.2,.
AU2013221420A 2012-02-16 2013-02-15 Methods of producing sulfilimine compounds Active AU2013221420B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261599489P 2012-02-16 2012-02-16
US61/599,489 2012-02-16
PCT/US2013/026377 WO2013123349A1 (en) 2012-02-16 2013-02-15 Methods of producing sulfilimine compounds

Publications (2)

Publication Number Publication Date
AU2013221420A1 AU2013221420A1 (en) 2014-09-25
AU2013221420B2 true AU2013221420B2 (en) 2017-07-13

Family

ID=48982761

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2013221420A Active AU2013221420B2 (en) 2012-02-16 2013-02-15 Methods of producing sulfilimine compounds

Country Status (19)

Country Link
US (2) US9227936B2 (en)
EP (1) EP2814812B1 (en)
JP (1) JP6138834B2 (en)
KR (1) KR102064827B1 (en)
CN (1) CN104271555B (en)
AR (1) AR090076A1 (en)
AU (1) AU2013221420B2 (en)
BR (1) BR102013003576B8 (en)
CA (1) CA2863994C (en)
CO (1) CO7081159A2 (en)
ES (1) ES2625106T3 (en)
IL (1) IL233956B (en)
IN (1) IN2014DN07442A (en)
MX (1) MX368125B (en)
PL (1) PL2814812T3 (en)
RU (1) RU2634718C2 (en)
UA (1) UA116628C2 (en)
WO (1) WO2013123349A1 (en)
ZA (1) ZA201406494B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105324365A (en) * 2012-12-11 2016-02-10 美国陶氏益农公司 Improved process for the preparation of n-cyano-s-[1 -(pyridin-3-yl)ethyl]-s-methylsulfilimines
EP3116870A1 (en) 2014-03-13 2017-01-18 Proteostasis Therapeutics, Inc. Compounds, compositions, and methods for increasing cftr activity
CA2942386A1 (en) 2014-03-13 2015-09-17 Proteostasis Therapeutics, Inc. Compounds, compositions, and methods for increasing cftr activity
US10174014B2 (en) 2014-06-19 2019-01-08 Proteostasis Therapeutics, Inc. Compounds, compositions, and methods for increasing CFTR activity
CA2971850A1 (en) 2014-12-23 2016-06-30 Proteostasis Therapeutics, Inc. Derivatives of 5-phenyl- or 5-heteroarylthiazol-2-carboxylic amide useful for the treatment of inter alia cystic fibrosis
US10344023B2 (en) 2014-12-23 2019-07-09 Proteostasis Therapeutics, Inc. Derivatives of 3-heteroarylisoxazol-5-carboxylic amide useful for the treatment of inter alia cystic fibrosis
WO2016105484A1 (en) 2014-12-23 2016-06-30 Proteostasis Therapeutics, Inc. Derivatives of 5-(hetero)arylpyrazol-3-carboxylic amide or 1-(hetero)aryltriazol-4-carboxylic amide useful for the treatment of inter alia cystic fibrosis
MA41253A (en) 2014-12-23 2017-10-31 Proteostasis Therapeutics Inc COMPOUNDS, COMPOSITIONS AND PROCESSES TO INCREASE THE ACTIVITY OF CFTR
AU2016297886B2 (en) 2015-07-24 2020-12-10 Proteostasis Therapeutics, Inc. Compounds, compositions and methods of increasing CFTR activity
CA3000483C (en) 2015-10-06 2024-02-13 Proteostasis Therapeutics, Inc. Compounds, compositions, and methods for modulating cftr
NZ746793A (en) 2016-04-07 2022-10-28 Proteostasis Therapeutics Inc Silicone atoms containing ivacaftor analogues
US10899751B2 (en) 2016-06-21 2021-01-26 Proteostasis Therapeutics, Inc. Compounds, compositions, and methods for increasing CFTR activity
TWI735573B (en) * 2016-06-21 2021-08-11 美商陶氏農業科學公司 Methods of manufacturing certain substituted sulfilimines

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5973148A (en) * 1996-11-13 1999-10-26 Dow Agrosciences Llc N-arylsulfilimine compounds and their use as catalysts in the preparation of N-arylarylsulfonamide compounds
US20050228027A1 (en) * 2004-04-08 2005-10-13 Yuanming Zhu Insecticidal N-substituted sulfoximines
US20080207910A1 (en) * 2007-02-26 2008-08-28 Dow Agrosciences Llc Process for the preparation of certain substituted sulfilimines

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2573733A (en) * 1950-01-03 1951-11-06 Celanese Corp Production of anthraquinone dyestuffs
US4085093A (en) 1976-07-23 1978-04-18 The Goodyear Tire & Rubber Company Sulfilimines as premature vulcanization inhibitors
FR2723370B1 (en) * 1994-08-02 1996-09-13 Roussel Uclaf NEW IMIDAZOLE DERIVATIVES, THEIR PREPARATION PROCESS, THE NEW INTERMEDIATES OBTAINED, THEIR APPLICATION AS MEDICAMENTS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
TWI387585B (en) * 2006-09-01 2013-03-01 Dow Agrosciences Llc Insecticidal n-substituted (heteroaryl)alkyl sulfilimines
TWI383970B (en) * 2006-11-08 2013-02-01 Dow Agrosciences Llc Multi-substituted pyridyl sulfoximines and their use as insecticides
WO2009014891A2 (en) * 2007-07-20 2009-01-29 Dow Agrosciences Llc Increasing plant vigor
CN101677570B (en) * 2008-05-01 2015-12-09 陶氏益农公司 Synergistic pesticidal mixtures
EA201200321A1 (en) * 2009-08-26 2012-09-28 Новартис Аг TETRA-SUBSTITUTED HETEROARRYL COMPOUNDS AND THEIR USE AS MDM2 AND / OR MDM4 MODULATORS
CN105324365A (en) * 2012-12-11 2016-02-10 美国陶氏益农公司 Improved process for the preparation of n-cyano-s-[1 -(pyridin-3-yl)ethyl]-s-methylsulfilimines

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5973148A (en) * 1996-11-13 1999-10-26 Dow Agrosciences Llc N-arylsulfilimine compounds and their use as catalysts in the preparation of N-arylarylsulfonamide compounds
US20050228027A1 (en) * 2004-04-08 2005-10-13 Yuanming Zhu Insecticidal N-substituted sulfoximines
US20080207910A1 (en) * 2007-02-26 2008-08-28 Dow Agrosciences Llc Process for the preparation of certain substituted sulfilimines

Also Published As

Publication number Publication date
JP6138834B2 (en) 2017-05-31
KR102064827B1 (en) 2020-01-13
EP2814812B1 (en) 2017-03-29
CA2863994C (en) 2020-06-16
BR102013003576A2 (en) 2015-06-16
CO7081159A2 (en) 2014-10-10
EP2814812A4 (en) 2015-07-01
CA2863994A1 (en) 2013-08-22
MX2014009922A (en) 2014-11-21
IN2014DN07442A (en) 2015-04-24
MX368125B (en) 2019-09-19
JP2015507018A (en) 2015-03-05
RU2634718C2 (en) 2017-11-03
CN104271555A (en) 2015-01-07
BR102013003576B1 (en) 2019-09-17
PL2814812T3 (en) 2017-10-31
WO2013123349A1 (en) 2013-08-22
IL233956B (en) 2018-08-30
CN104271555B (en) 2017-06-06
US9884824B2 (en) 2018-02-06
US20160046580A1 (en) 2016-02-18
BR102013003576B8 (en) 2022-10-11
US20130217883A1 (en) 2013-08-22
AU2013221420A1 (en) 2014-09-25
ES2625106T3 (en) 2017-07-18
RU2014137257A (en) 2016-04-10
ZA201406494B (en) 2016-12-21
EP2814812A1 (en) 2014-12-24
UA116628C2 (en) 2018-04-25
IL233956A0 (en) 2014-09-30
KR20140127320A (en) 2014-11-03
US9227936B2 (en) 2016-01-05
AR090076A1 (en) 2014-10-15

Similar Documents

Publication Publication Date Title
AU2013221420B2 (en) Methods of producing sulfilimine compounds
US8962850B2 (en) Nitrogen-containing heterocyclic compound and method for producing same
KR20150122854A (en) Process for preparing 1,2-hexanediol
EP2141151B1 (en) Method for producing 2-haloimidazole compound
JP2015524426A (en) Novel production method of 1-oxacephalosporin derivative
JP2008531487A5 (en)
RU2012149696A (en) ALTERNATIVE TO TETRASENE
KR101292750B1 (en) Novel method for preparing 1-oxacephalosporin derivatives
JP2011016782A (en) Method for producing glycolic acid, and glycolic acid-containing composition
JP6477187B2 (en) Process for producing 2-amino-6-methylnicotinic acid ester
DE2221771C3 (en) Process for the preparation of α-iminonitriles
JP2013023475A (en) Method for producing 1,3-diiodohydantoins
WO2019025017A1 (en) Process for the preparation of elafibranor and novel synthesis intermediates
CN111556872B (en) Synthesis of borate derivatives and uses thereof
EP0404175B1 (en) Process for preparing imidazole derivatives
RU2703529C2 (en) Method for selective production of fullerene quadricyclan derivatives
AU2014201037B2 (en) Nitrogen-containing heterocyclic compound and method for producing same
CN111556872A (en) Synthesis of boronic ester derivatives and uses thereof
AU2012247128A1 (en) A process for preparation of dicyanocarboxylate derivatives
JP2017202992A (en) Method for producing (trifluoromethyl)malonic acid ester

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
HB Alteration of name in register

Owner name: CORTEVA AGRISCIENCE LLC

Free format text: FORMER NAME(S): DOW AGROSCIENCES, LLC